Atom | Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R01 Clinical Trial Optional)

Funder: National Institutes of Health

Due Dates: August 14, 2025 (New/Renewal/Resubmission/Revision) | January 16, 2026 (New/Renewal/Resubmission/Revision) | August 14, 2026 (New/Renewal/Resubmission/Revision)

Funding Amounts: $1.5M/year (total for all awards); up to 6 awards; budgets not limited but must reflect project needs; max project period 5 years.

Summary: Supports clinical research to identify and validate novel non-invasive brain stimulation targets and mechanistic responses for substance use disorder treatment.

Key Information: Requires a Plan for Enhancing Diverse Perspectives (PEDP); applications without a PEDP will be withdrawn.

Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R01 Clinical Trial Optional)

Sign in to see full grant listing